三鑫医疗
(300453)
| 流通市值：28.24亿 | | | 总市值：41.37亿 |
| 流通股本：3.57亿 | | | 总股本：5.22亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 360,576,957.37 | 1,500,438,417.74 | 1,082,325,012.3 | 686,452,593.92 |
| 营业收入 | 360,576,957.37 | 1,500,438,417.74 | 1,082,325,012.3 | 686,452,593.92 |
| 二、营业总成本 | 298,171,216 | 1,237,481,684.14 | 893,134,673.4 | 567,971,594.42 |
| 营业成本 | 235,743,644.7 | 970,338,340.01 | 703,175,490.86 | 445,557,916.04 |
| 税金及附加 | 3,137,856.61 | 12,326,561.24 | 8,820,225.96 | 5,424,437.95 |
| 销售费用 | 16,620,146.83 | 84,057,182.63 | 63,736,706.58 | 43,005,654.4 |
| 管理费用 | 26,825,689.68 | 107,953,051.15 | 73,168,404.16 | 46,176,422.84 |
| 研发费用 | 16,250,108.87 | 63,977,820.58 | 44,733,074.43 | 28,271,170.34 |
| 财务费用 | -406,230.69 | -1,171,271.47 | -499,228.59 | -464,007.15 |
| 其中:利息费用 | 436,528.27 | 3,114,826.36 | 3,009,155.59 | 1,986,067.39 |
| 其中:利息收入 | 307,575.5 | 2,203,530.26 | 1,992,735.27 | 1,693,850.85 |
| 加:公允价值变动收益 | 1,102,043.71 | -2,159,105.95 | 7,630,716.17 | 5,277,284.63 |
| 加:投资收益 | -581,551.39 | 10,237,398.3 | -283,479.34 | -159,917.33 |
| 资产处置收益 | -141,491.17 | 190,079.24 | 192,035.52 | 192,035.52 |
| 资产减值损失(新) | -86,809.82 | -10,578,392.04 | 46,637.99 | 117,351.93 |
| 信用减值损失(新) | -883,213.83 | -3,412,355.77 | -1,770,874.78 | -969,456.32 |
| 其他收益 | 5,626,292.19 | 21,615,223.57 | 11,601,669.75 | 9,839,416.09 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 67,441,011.06 | 278,849,580.95 | 206,607,044.21 | 132,777,714.02 |
| 加:营业外收入 | 100,539.7 | 2,316,420.72 | 2,208,989.07 | 471,624.27 |
| 减:营业外支出 | 855,254.89 | 5,105,271.07 | 2,739,368.23 | 2,243,870.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 66,686,295.87 | 276,060,730.6 | 206,076,665.05 | 131,005,467.94 |
| 减:所得税费用 | 7,311,050.35 | 28,356,584.95 | 22,732,726.68 | 15,623,714.47 |
| 六、净利润 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 | 115,381,753.47 |
| 持续经营净利润 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 | 115,381,753.47 |
| 归属于母公司股东的净利润 | 53,725,693.38 | 227,404,091.13 | 167,914,693.97 | 106,247,789.77 |
| 少数股东损益 | 5,649,552.14 | 20,300,054.52 | 15,429,244.4 | 9,133,963.7 |
| (一)基本每股收益 | 0.1 | 0.44 | 0.32 | 0.2 |
| (二)稀释每股收益 | 0.1 | 0.44 | 0.32 | 0.2 |
| 九、综合收益总额 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 | 115,381,753.47 |
| 归属于母公司股东的综合收益总额 | 53,725,693.38 | 227,404,091.13 | 167,914,693.97 | 106,247,789.77 |
| 归属于少数股东的综合收益总额 | 5,649,552.14 | 20,300,054.52 | 15,429,244.4 | 9,133,963.7 |
| 公告日期 | 2025-04-28 | 2025-03-27 | 2024-10-15 | 2024-08-10 |
| 审计意见(境内) | | 标准无保留意见 | | |